These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 27013587

  • 21. Effects of exposure to polycyclic aromatic hydrocarbons combined with high-risk human papillomavirus infection on cervical intraepithelial neoplasia: A population study in Shanxi Province, China.
    Li X, Ding L, Song L, Gao W, Wang L, Wang J.
    Int J Cancer; 2020 May 01; 146(9):2406-2412. PubMed ID: 31290154
    [Abstract] [Full Text] [Related]

  • 22. Relationship between cervical disease and infection with human papillomavirus types 16 and 18, and herpes simplex virus 1 and 2.
    Zhao Y, Cao X, Zheng Y, Tang J, Cai W, Wang H, Gao Y, Wang Y.
    J Med Virol; 2012 Dec 01; 84(12):1920-7. PubMed ID: 23080497
    [Abstract] [Full Text] [Related]

  • 23. Prevalence of alpha-papillomavirus genotypes in cervical squamous intraepithelial lesions and invasive cervical carcinoma in the Italian population.
    Tornesello ML, Duraturo ML, Botti G, Greggi S, Piccoli R, De Palo G, Montella M, Buonaguro L, Buonaguro FM, Italian HPV Working Group.
    J Med Virol; 2006 Dec 01; 78(12):1663-72. PubMed ID: 17063505
    [Abstract] [Full Text] [Related]

  • 24. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer.
    Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM.
    Cancer Epidemiol Biomarkers Prev; 2005 May 01; 14(5):1157-64. PubMed ID: 15894666
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The prevalence and genotype distribution of human papilloma virus in cervical squamous intraepithelial lesion and squamous cell carcinoma in Taizhou, China.
    Jin R, Yang X, Bao J, Zhang W, Dou R, Yuan D, Yang Q, Jiang L, Yu H.
    Medicine (Baltimore); 2021 Jul 16; 100(28):e26593. PubMed ID: 34260540
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Cervical intraepithelial neoplasia grade 2 or worse in Galicia, Spain: HPV 16 prevalence and vaccination impact.
    Pérez-Castro S, Lorenzo-Mahía Y, Iñarrea Fernández A, Lamas-González MJ, Sarán-Díez MT, Rubio-Alarcón J, Reboredo-Reboredo MC, Mosteiro-Lobato S, López-Miragaya I, Torres-Piñón J, Melón-García S.
    Enferm Infecc Microbiol Clin; 2014 Oct 16; 32(8):479-85. PubMed ID: 24274937
    [Abstract] [Full Text] [Related]

  • 30. Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology.
    Stoler MH, Wright TC, Parvu V, Yanson K, Cooper CK, Andrews J.
    Gynecol Oncol; 2019 Apr 16; 153(1):26-33. PubMed ID: 30638767
    [Abstract] [Full Text] [Related]

  • 31. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
    Song F, Yan P, Huang X, Wang C, Du H, Qu X, Wu R.
    BMC Cancer; 2022 Jan 06; 22(1):42. PubMed ID: 34991494
    [Abstract] [Full Text] [Related]

  • 32. Risk stratification of cervical lesions using capture sequencing and machine learning method based on HPV and human integrated genomic profiles.
    Tian R, Cui Z, He D, Tian X, Gao Q, Ma X, Yang JR, Wu J, Das BC, Severinov K, Hitzeroth II, Debata PR, Xu W, Zhong H, Fan W, Chen Y, Jin Z, Cao C, Yu M, Xie W, Huang Z, Bao Y, Xie H, Yao S, Hu Z.
    Carcinogenesis; 2019 Oct 16; 40(10):1220-1228. PubMed ID: 31102403
    [Abstract] [Full Text] [Related]

  • 33. Human papilloma virus prevalence, genotype distribution, and pattern of infection in Thai women.
    Suthipintawong C, Siriaunkgul S, Tungsinmunkong K, Pientong C, Ekalaksananan T, Karalak A, Kleebkaow P, Vinyuvat S, Triratanachat S, Khunamornpong S, Chongsuwanich T.
    Asian Pac J Cancer Prev; 2011 Oct 16; 12(4):853-6. PubMed ID: 21790214
    [Abstract] [Full Text] [Related]

  • 34. Characterization of HPV subtypes not covered by the nine-valent vaccine in patients with CIN 2-3 and cervical squamous cell carcinoma.
    Ma MJ, Wang YN, Zhu JF, Wang XY, Jin YB, Liu XN, Wu SF, Yang YB.
    Curr Probl Cancer; 2021 Dec 16; 45(6):100761. PubMed ID: 34154817
    [Abstract] [Full Text] [Related]

  • 35. Human Papillomavirus Genotype Distribution among Thai Women with High-Grade Cervical Intraepithelial Lesions and Invasive Cervical Cancer: a Literature Review.
    Kietpeerakool C, Kleebkaow P, Srisomboon J.
    Asian Pac J Cancer Prev; 2015 Dec 16; 16(13):5153-8. PubMed ID: 26225645
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Is human papillomavirus genotype important in predicting disease progression in women with biopsy-proven negative or CIN1 of atypical squamous cell of undetermined significance (ASC-US) cytology?
    Kang WD, Ju UC, Kim SM.
    Gynecol Oncol; 2018 Feb 16; 148(2):305-310. PubMed ID: 29183629
    [Abstract] [Full Text] [Related]

  • 38. Attribution of human papillomavirus types to cervical intraepithelial neoplasia and invasive cancers in Southern China.
    Chan PK, Cheung TH, Li WH, Yu MY, Chan MY, Yim SF, Ho WC, Yeung AC, Ho KM, Ng HK.
    Int J Cancer; 2012 Aug 01; 131(3):692-705. PubMed ID: 21976212
    [Abstract] [Full Text] [Related]

  • 39. Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women.
    Hosaka M, Fujita H, Hanley SJ, Sasaki T, Shirakawa Y, Abiko M, Kudo M, Kaneuchi M, Watari H, Kikuchi K, Sakuragi N.
    Int J Cancer; 2013 Jan 15; 132(2):327-34. PubMed ID: 22729477
    [Abstract] [Full Text] [Related]

  • 40. Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants.
    Wang SS, Zuna RE, Wentzensen N, Dunn ST, Sherman ME, Gold MA, Schiffman M, Wacholder S, Allen RA, Block I, Downing K, Jeronimo J, Carreon JD, Safaeian M, Brown D, Walker JL.
    Cancer Epidemiol Biomarkers Prev; 2009 Jan 15; 18(1):113-20. PubMed ID: 19124488
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.